We look at a slew of articles that talk about amazing new things about GLP-1 this week:

1. Glaucoma Reduction Potential
2. Prescription Trends
3. SGLP2 Inhibitors vs. GLP1: Kidney Outcomes for Diabetics
4. How GLP1s are having impacts in multiple sectors
5. Tirzepatide/GLP1ra in Type II Diabetes
6. Concerns & Issues related to GLP1s

All this and more in this power packed episode!